
USD
+$0.00
(+0.00%
)At Close (As of Dec 12, 2025)
$250.53B
Market Cap
13.27
P/E Ratio
7.56
EPS
$105.84
52 Week High
$71.87
52 Week Low
HEALTHCARE
Sector
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-12-15 |
| Declaration Date | 2025-11-18 |
| Record Date | 2025-12-15 |
| Payment Date | 2026-01-08 |
| Amount | 0.85 |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - GENERAL
Merck & Company Inc. is a leading American multinational pharmaceutical corporation based in Kenilworth, New Jersey, renowned for its commitment to advancing global health through innovative pharmaceuticals and vaccines. Founded in 1891, the company has a distinguished history of scientific breakthroughs, primarily focusing on oncology, infectious diseases, and cardiovascular therapeutics. Merck maintains a strong clinical pipeline and invests heavily in research and development, solidifying its status as a frontrunner in the biopharmaceutical industry. With a dedication to improving patient outcomes and ensuring healthcare accessibility, Merck leverages its scientific expertise and strategic partnerships to navigate the dynamic healthcare landscape, positioning itself for sustained growth and innovation.